Loading ticker data...
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| 2022-05-06 | Hickey David | EVP & President, Life Sciences | Sell | 475 | $256.00 | $121,600.00 | -11.1% | → |
| 2022-02-25 | Larson Betty D | EVP HR & CHRO | Sale+OE | 14,374 | $271.90 | $3,908,290.60 | -23.4% | → |
| 2022-02-08 | Fraser Claire | Director | Sell | 841 | $271.70 | $228,499.70 | -3.8% | → |
| 2022-02-03 | Conroy Alexandre | EVP of Integrated Supply Chain | Sale+OE | 6,410 | $270.16 | $1,731,725.60 | -23.2% | → |
| 2021-12-16 | Larson Betty D | EVP HR & CHRO | Sale+OE | 3,341 | $255.00 | $851,955.00 | -18.7% | → |
| 2021-12-07 | Spoerel Thomas J | VP Controller & Chief Acct Off | Sell | 233 | $250.00 | $58,250.00 | -17.8% | → |
| 2021-09-08 | Spoerel Thomas J | VP Controller & Chief Acct Off | Sell | 267 | $260.00 | $69,420.00 | -20.8% | → |
| 2021-09-08 | Hickey David | EVP & President, Life Sciences | Sell | 500 | $260.00 | $130,000.00 | -12.2% | → |
| 2021-09-08 | RIMEL REBECCA W | - | Sell | 500 | $260.00 | $130,000.00 | -4.5% | → |
| 2021-09-03 | Lim James C | Executive Vice President | Sale+OE | 6,956 | $257.44 | $1,790,752.64 | -26.0% | → |
| 2021-09-03 | RIMEL REBECCA W | - | Sell | 500 | $257.10 | $128,550.00 | -4.3% | → |
| 2021-09-02 | RIMEL REBECCA W | - | Sell | 244 | $254.00 | $61,976.00 | -2.1% | → |
| 2021-08-30 | RIMEL REBECCA W | - | Sell | 207 | $252.00 | $52,164.00 | -1.7% | → |
| 2021-08-18 | Fraser Claire | - | Sell | 387 | $251.58 | $97,361.46 | -1.9% | → |
| 2021-08-17 | RIMEL REBECCA W | - | Sell | 207 | $252.00 | $52,164.00 | -1.7% | → |
| 2021-08-06 | Spoerel Thomas J | VP Controller & Chief Acct Off | Sell | 266 | $242.30 | $64,451.80 | -17.2% | → |
| 2021-05-28 | Lim James C | Executive Vice President | Sell | 3,429 | $241.68 | $828,720.72 | -81.1% | → |
| 2021-05-27 | Fraser Claire | - | Sell | 390 | $241.36 | $94,130.40 | -1.9% | → |
| 2020-11-23 | Goette Roland | EVP and President, EMEA | Sale+OE | 930 | $230.10 | $213,993.00 | -10.4% | → |
| 2020-07-09 | Kaltenbach Patrick | EVP & Pres Life Sciences | Sell | 1,272 | $260.00 | $330,720.00 | -11.0% | → |
| 2020-06-05 | Kaltenbach Patrick | EVP & Pres Life Sciences | Sell | 1,049 | $243.20 | $255,116.80 | -8.3% | → |
| 2020-06-02 | Kaltenbach Patrick | EVP & Pres Life Sciences | Sell | 222 | $244.83 | $54,352.26 | -1.5% | → |
| 2020-05-08 | Fraser Claire | Director | Sell | 771 | $256.56 | $197,807.76 | -3.7% | → |
| 2020-03-16 | Khichi Samrat S. | EVP and General Counsel | Sell | 4,349 | $224.53 | $976,480.97 | -45.3% | → |
| 2020-02-11 | Fraser Claire | Director | Sell | 1,500 | $258.72 | $388,074.00 | -3.4% | → |
| 2020-02-04 | Campion Simon D | EVP and Segment President | Sale+OE | 8,085 | $285.09 | $2,304,952.65 | -13.1% | → |
| 2020-02-04 | Mas Ribo Alberto | EVP and Pres, Life Sciences | Sell | 1,430 | $285.00 | $407,550.00 | -14.6% | → |
| 2020-01-28 | FORLENZA VINCENT A | Chairman, CEO and President | Sale+OE | 28,514 | $280.96 | $8,011,293.44 | -12.0% | → |
| 2020-01-27 | FORLENZA VINCENT A | Chairman, CEO and President | Sale+OE | 39,007 | $280.09 | $10,925,569.19 | -5.9% | → |
| 2020-01-10 | FORLENZA VINCENT A | Chairman, CEO and President | Sale+OE | 33,535 | $275.17 | $9,227,709.65 | -7.4% | → |
| 2020-01-02 | FORLENZA VINCENT A | Chairman, CEO and President | Sale+OE | 33,365 | $271.28 | $9,051,257.20 | -13.8% | → |
| 2019-12-16 | Polen Thomas E Jr | Executive Vice President | Sale+OE | 6,386 | $269.63 | $1,721,857.18 | -15.7% | → |
| 2019-12-16 | Mas Ribo Alberto | EVP and Pres, Life Sciences | Sale+OE | 11,860 | $269.51 | $3,196,388.60 | -54.7% | → |